We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Negative Effects Seen from Revised Mammography Recommendation for Women Ages 40-49

By HospiMedica International staff writers
Posted on 17 May 2011
Two new studies revealed that a US task force's recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection. More...


After the United States Preventative Services Task Force's (USPSTF; Rockville, MD, USA) delivered their recommendations in November 2009, researchers at the University of Colorado (Boulder, USA) saw considerable decrease of mammograms in women aged 40-49. "In the nine months after the guidelines, we saw 205 fewer women in the 40-49 age group than we did the previous year,” said Dr. Lara Hardesty, lead researcher for this study.

Correspondingly, researchers from the University Hospitals at Case Medical Center (Cleveland, OH, USA) performed a retrospective review to determine the potential impact of forgoing screening mammograms in this patient population. "These guidelines greatly concerned us, especially for our patients and primary physicians,” said Dr. Donna Plecha. "We know that when patients are screened earlier, they have a better prognosis for detection and treatment.”

In the study at the University Hospitals at Case Medical Center, out of the 524 biopsies performed, 108 cases of cancer were diagnosed. Tumors discovered in the 40 to 49-year-old patients who underwent screening mammography presented at a much earlier stage of breast cancer than those patients who did not have screening mammograms. Dr. Plecha believes that if primary physicians and patients begin following the USPSTF's guidelines, survival rates in this population will decline. She said, "Seventy percent of women who are diagnosed with breast cancer don't have a family history of breast cancer. It's very important that we continue to do all that we can to catch breast cancer in the earliest stages so that we can continue to save lives.”

Dr. Hardesty also emphasized the importance of stressing the benefits of yearly mammograms to 40-49 year old patients and physicians alike. She concluded, "We must continue to get the message out to our patients and make sure that referring providers understand our recommendations because they are the ones who are influencing patients in that age group.”

Dr. Hardesty and Dr. Plecha delivered presented findings on their studies on May 2, 2011, at the 2011 American Roentgen Ray Society (ARRS) annual meeting held in Chicago (IL, USA).

Related Links:

United States Preventative Services Task Force
University of Colorado
University Hospitals at Case Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.